Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NADPH oxidase 2 (NOX2), also known as the phagocyte NADPH oxidase or cytochrome b-245, is a multi-subunit enzyme complex primarily located in the membranes of neutrophils and other phagocytes. Its primary biological function is the generation of reactive oxygen species (ROS), such as superoxide, through a process known as the respiratory burst, which is critical for the destruction of engulfed pathogens (Lambeth, 2004). The activation of NOX2 is a highly regulated process involving the phosphorylation of cytosolic subunits (such as p47phox, p67phox, and p40phox) by kinases like Protein Kinase C (PKC), followed by their translocation to the membrane-bound cytochrome b-245 complex (Fontayne et al., 2002). While essential for innate immunity, excessive or chronic ROS production by NOX2 is implicated in the pathogenesis of various inflammatory and cardiovascular diseases, including atherosclerosis, hypertension, and neurodegenerative disorders (Drummond et al., 2011). Therapeutic strategies targeting NOX2 aim to modulate ROS levels to prevent tissue damage, though complete inhibition carries the risk of inducing an immunodeficient state similar to Chronic Granulomatous Disease (CGD) (Bedard & Krause, 2007).
Inhibition of the assembly or catalytic activity of the NADPH oxidase enzyme complex to prevent the transfer of electrons from NADPH to molecular oxygen, thereby reducing the production of superoxide anions.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADPH oxidase 2 (NOX2) (NOX2).